IDEAYA Biosciences, Inc., a precision medicine oncology company, develops targeted therapeutics for patient populations selected using molecular diagnostics in the United States. The company offers Darovasertib, an oral, potent, and selecti...
Q2 2026
Aug 10, 2026
Q1 2026
May 5, 2026
FY 2025
Feb 17, 2026
Q4 2025
Q3 2025
Nov 4, 2025
